Show menu

Latest news from SEQENS Group

Lorem ipsum dolor sit amet consectetur. Eu justo in urna scelerisque venenatis faucibus felis at dui. Et eu quam leo vestibulum. Nulla feugiat quis imperdiet eu gravida sit aliquam tellus proin. Ipsum quis dui duis vel vulputate. Eget quisque morbi pretium facilisi. Malesuada velit faucibus eget at quisque ultrices. Quis tortor auctor eget mauris nibh tincidunt purus tortor.

Enim nisi neque id magna volutpat pellentesque phasellus diam urna. Risus ipsum non sodales sed ac quis. Donec ultricies iaculis eleifend aliquam ut. Purus nisl parturient venenatis enim sapien tellus adipiscing lorem viverra. Blandit dolor penatibus montes erat ut bibendum velit. Sodales dui egestas sit pharetra. Turpis vitae sit integer eget lobortis. Tellus nunc morbi rhoncus cursus nisi gravida lorem. Sit mi tortor auctor ut. Condimentum lacus tortor odio arcu sagittis nullam venenatis. Mauris bibendum lacinia id tempor amet pellentesque nunc. Mollis aliquam commodo massa elementum venenatis tortor pulvinar quam eu. Quam quis semper massa vitae fringilla semper. Vulputate euismod ultrices tempor egestas nibh eget.

image
SEQENS announces the appointement of a new CEO
France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued
Read more
image
SEQENS and APPLEXION announce strategic partnership for the distribution of SEQENZYM FT
Read more
image
Smart Immune and CELLforCURE by SEQENS partner to industrialize SMART101 clinical batches manufacturing
Read more
image
Arkema Grants an Exclusive Technology License to SEQENS to manufacture PEKK
Read more
image
European Industry Summit: Pierre Luzeau, CEO of Seqens joins 73 industry leaders to call for a European Industrial Deal
Read more
image
Seqens and KK India petroleum specialties PVT LTD announce new partnership for lubricant additives in India
Read more
image
Seqens partners with Pleryon to develop and manufacture an innovative GMP Polymer to treat osteoarthritis
Read more
image
Seqens confirms the acquisition of CELLforCURE
Read more
image
SEQENS Makes Multi-Million-Dollar Investment in U.S. R&D Laboratory
Read more
image
SK Capital becomes the new majority shareholder of Seqens – Q&A
Read more
image
Raw materials, energy and transport: rising prices & availability
Read more
image
SEQENS unveils its new pharmaceutical quality control laboratory in the presence of Jean Castex, French Prime Minister.
Read more
image
Eurazeo announces that it has entered into exclusive discussions to sell its stake in SEQENS
Read more
1 2 3